EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two new Nephrology TreatmentTrends(TM) publications based on survey results from 204 Nephrologists and 201 Renal Dietitians in the US. Renal Dietitians (RDs) are an integral part of the management of dialysis patients, particularly in their role recommending and reinforcing adherence with Phosphate Binders, Active Vitamin D, and Calcimimetic agents.
In the phosphate binder market, the introduction of Genzyme's Renvela has given overall sevelamer share a boost compared to the same quarter last year, although most of the patients on Renvela have been switched from Renagel. Close to two-thirds of MDs and over three quarters of RDs have used Renvela in their hemodialysis patients, however, Renagel and FMC's PhosLo remain the two most frequently prescribed binders among dialysis patients. While sevelamer has the highest share across all types of dialysis units, Shire's Fosrenol does its best in Davita units whereas PhosLo does its best in Fresenius units. Nephrologists are divided as to their first line preference in dialysis -- approximately half choose a calcium-based binder and half choose a non-calcium based binder compared to over two-thirds of RDs who choose to start with a non-calcium based binder. In patients with Chronic Kidney Disease not on dialysis (CKD), 73% of Nephrologists prefer to start with calcium-based binders.
In the PTH modifier market, although RDs report a high level of
influence in the choice of Vitamin D, approximately 80% report that their
dialysis center generally encourages the use of Abbott's Zemplar, compared
to only 29% who report they are encouraged to use Genzyme's Hectorol. While
Zemplar IV is the overwhelming market share leader in hemodialysis and
leads in every type of dialysis unit, Hectorol does its best in non-chains
and its worst in Davita. In CKD, Nephrologists continue to use oral
calcitriol most often. Compared to the prior year, R
|SOURCE BioTrends Research Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved